NCT03224117View on ClinicalTrials.gov

Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 26, 2017

Primary Completion Date

June 29, 2018

Study Completion Date

June 29, 2018

Conditions
Treatment for Submental Fat
Interventions
DRUG

DWJ211

inject the Drug into submental fat via subcutaneous

DRUG

Normal saline

inject the Drug into submental fat via subcutaneous

Trial Locations (3)

Unknown

Chung-ang university hospital, Seoul

Konkuk university medical center, Seoul

Seoul Asan medical center, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY